AR and prostate carcinoma: Immunofluorescence, Co-IP, and WB experiments confirmed that VP significantly inhibited YAP nuclear translocation and the AR-YAP interaction (32).YAP not only plays a crucial role in tumor cell proliferation and invasion but has also been demonstrated to induce cancer stemness in prostate cancer, thus promoting enzalutamide resistance (113).